The Cardiac Resynchronization Therapy Device (CRT-D) market is a subset of the larger cardiovascular device market. It is composed of devices used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. CRT-D devices are designed to improve the coordination of the heart's pumping action, allowing it to pump more efficiently. These devices are typically implanted in the chest and are connected to the heart via wires. CRT-D devices are used to treat a variety of heart conditions, including atrial fibrillation, ventricular tachycardia, and congestive heart failure. They are also used to reduce the risk of sudden cardiac death. The CRT-D market is highly competitive, with a number of major players. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, Biotronik, and Sorin Group. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
